• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

    6/2/25 3:00:00 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email

    New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence

    LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions.

    Clarivate logo (PRNewsfoto/Clarivate Analytics)

    As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to  solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index.

    By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines.

    Matti Shem Tov, Chief Executive Officer, Clarivate, said: "This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond."

    Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference."

    The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement.

    Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas.

    By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research.

    Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights.

    To learn more about this partnership and the solutions now available to CAPES institutions, visit here.

    Notes to editors

    According to the most recent Institute for Scientific Information G20 research and innovation scorecard:

    • Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact.
    • Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average.
    • More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average.
    • Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average.

    About Clarivate

    Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

    About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

    Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields.

    Media contacts: 

    Clarivate

    Rebecca Krahenbuhl

    Senior Manager, External Communications – Academia & Government

    [email protected]

    Catherine Daniel

    Director, External Communications – Life Sciences & Healthcare

    [email protected]

    CAPES

    João Mendes

    Communications

    [email protected]  

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-and-capes-expand-landmark-partnership-to-power-research-and-innovation-across-brazil-302469715.html

    SOURCE Clarivate Plc

    Get the next $CLVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    1/8/2026$3.60Buy → Neutral
    Goldman
    12/17/2025$3.00Equal-Weight → Underweight
    Morgan Stanley
    9/3/2025Peer Perform
    Wolfe Research
    7/18/2025$4.50Buy → Hold
    Jefferies
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cornick Kenneth L. bought $345,000 worth of Ordinary Shares (100,000 units at $3.45) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/13/25 8:51:35 AM ET
    $CLVT
    EDP Services
    Technology

    Director Cornick Kenneth L. bought $2,482,000 worth of Ordinary Shares (725,000 units at $3.42) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 7:20:21 PM ET
    $CLVT
    EDP Services
    Technology

    Director Snyder Andrew Miles bought $4,861,800 worth of Ordinary Shares (1,460,000 units at $3.33) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 5:16:01 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clarivate Reveals the AI50 - the Organizations Leading Artificial Intelligence Invention

    LONDON, March 26, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in high-impact artificial intelligence (AI) inventions. Following our announcement of the Top 100 Global Innovators 2026, this report dives deeper into the AI world, where organizations such as NVIDIA, Micron Technology, Alphabet, Qualcomm or Foxconn are creating foundational capability in AI, translating AI into complex systems, and scaling into p

    3/26/26 4:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude

    Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflowsLONDON, March 10, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate's proprietary regulatory intelligence with Claude's AI reasoning capabilities. The collaboration gives biopharma, biotech, medtech and clinical research organizations intelligent, context-aware access to authoritative regulatory data within the AI workflows they already use.

    3/10/26 4:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate to Present at the Wolfe Research FinTech Forum on March 10

    LONDON, March 4, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Wolfe Research FinTech Forum, on Tuesday, March 10, 2026 at 10:55 am Eastern Time. The live webcast can be accessed at https://event.summitcast.com/view/6TbwwRgcrsMqMH9MnDuEEt/guest_book?session_id=SKXtYVEftt9CfQ9kjfMcvp and will be available for replay. A replay of the webcast will also be available on https://ir.clarivate.com and will remain ava

    3/4/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Clarivate Plc

    DEFA14A - CLARIVATE PLC (0001764046) (Filer)

    4/1/26 8:06:00 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form DEF 14A filed by Clarivate Plc

    DEF 14A - CLARIVATE PLC (0001764046) (Filer)

    4/1/26 7:56:11 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    3/26/26 4:13:46 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cornick Kenneth L.

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:46 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form 4 filed by Bomba Jane L Okun

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:40 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form 4 filed by Snyder Andrew Miles

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:33 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clarivate downgraded by Goldman with a new price target

    Goldman downgraded Clarivate from Buy to Neutral and set a new price target of $3.60

    1/8/26 8:37:08 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Clarivate from Equal-Weight to Underweight and set a new price target of $3.00

    12/17/25 8:52:26 AM ET
    $CLVT
    EDP Services
    Technology

    Wolfe Research initiated coverage on Clarivate

    Wolfe Research initiated coverage of Clarivate with a rating of Peer Perform

    9/3/25 8:37:02 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    View All

    VideoAmp Expands Board with Former Tech and Data Industry Leaders Jonathan Gear and Sari Granat

    Seasoned executives from Clarivate, IHS Markit and Chainalysis join to guide next-phase innovation and scaling at VideoAmp VideoAmp, a leading advertising technology company, today announced the appointment of Jonathan Gear and Sari Granat to its Board of Directors. Gear and Granat bring extensive leadership experience across information services, SaaS, analytics, and global technology, strengthening VideoAmp's mission to modernize measurement and deliver higher fidelity, outcome-based currency for the industry. Jonathan Gear most recently served as Chief Executive Officer of Clarivate (NYSE:CLVT), a global information and analytics company, where he led a strategic repositioning to drive

    12/2/25 9:00:00 AM ET
    $AIZ
    $CLVT
    $INFO
    Property-Casualty Insurers
    Finance
    EDP Services
    Technology

    Clarivate Announces Maroun S. Mourad as President, Intellectual Property

    LONDON, July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025. Maroun most recently served as President of the Claims Solutions division of Verisk Analytics Inc. He succeeds Gordon Samson, who will retire at the end of 2025 after a high-impact career in the IP industry, spending five years as the Chief Operating Officer at CPA Global, before joining the Clarivate executive team, most recently as the President of the IP segment.

    7/30/25 6:01:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

    Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

    4/26/23 7:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Clarivate Plc

    SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

    12/5/24 10:02:09 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13G filed by Clarivate Plc

    SC 13G - CLARIVATE PLC (0001764046) (Subject)

    11/13/24 4:18:30 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

    SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

    3/4/24 9:01:44 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Financials

    Live finance-specific insights

    View All

    Clarivate Reports Fourth Quarter and Full Year 2025 Results

    — Value Creation Plan accelerated organic ACV and drove higher cash flow in 2025 —— Financial outlook for 2026 projects continued momentum —— Provides update on strategic review; Currently engaged in active discussions with interested parties to sell Life Sciences & Healthcare business —LONDON, Feb. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2025. Executive CommentaryMatti Shem Tov, Chief Executive Office

    2/24/26 6:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

    LONDON, Jan. 28, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth quarter and full year 2025 before the market opens on Tuesday, February 24, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, February 24, 2026 to review the results. The webcast is o

    1/28/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology